Table 2.
Control group No. (%) |
BC patients No. (%) |
P-value | OR (95% CI) | |
---|---|---|---|---|
Anti- VCA IgG (n) | 220 | 142 | ||
Seronegative | 40 (18.2) | 22 (15.5) | Reference | |
Seropositive | 180 (81.8) | 120 (84.5) | 0.507 | 1.2 (0.68-2.14) |
EBNA-1 gene (n) | 180 | 120 | ||
Negative | 142 (78.9) | 66 (55) | Reference | |
Positive | 38 (21.1) | 54 (45) | <0.001 | 3.05 (1.84-5.07) |
EBV, Epstein-Barr virus; VCA, Viral capsid antigen; EBNA, Epstein Barr virus nuclear antigen; BC, breast cancer.